up, page-22

2.6 seemed cheap for the options.
Will wait and see.

On the 8th of feb southern cross had BOD as a spec buy
with a price target of 18c

On the 28th of feb after the merger announcement,
it was under review.

On the 1st of June 2011 they have BOD as a spec buy
with a price target of 18c

That's with the new market cap after merger.

All on BioMd website.

They had high regard for biomd management and that shouldn't change with new people on board.